This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Tetra, Sia. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovations of Anatolijs Misnovs
Introduction
Anatolijs Misnovs is a notable inventor based in Riga, Latvia. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on acetylsalicylic acid salts. His research has the potential to impact various medical treatments and improve patient outcomes.
Latest Patents
Anatolijs Misnovs holds a patent for novel betaine salts of acetylsalicylic acid. This includes the 4-trimethylammoniobutanoate acetylsalicylic acid addition salt, L-carnitine acetylsalicylic acid addition salt, and 3-(trimethylammonioamino)propanoate (meldonium) acetylsalicylic acid addition salt. His work highlights the use of meldonium acetylsalicylate as an antiplatelet agent for treating various pathologies induced by platelet aggregation, as well as its anti-inflammatory and antihyperlipidemic properties.
Career Highlights
Anatolijs Misnovs is associated with Tetra, Sia, where he continues to develop his innovative ideas. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Anatolijs has collaborated with notable colleagues, including Ivars Kalvins and Anatolijs Birmans. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Anatolijs Misnovs exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations are paving the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile